Consequently, an increasing number of studies have reported an the association between RACGAP1 overexpression in several types of cancers, including stomach15, breast16,17, colorectal18, bladder19, liver20, and uterine cancers21, indicating its possible role in tumor proliferation, migration, and recurrence. Here, RACGAP1 is linked to neoplasm.